Abbott Laboratories
NYSE:ABT

Watchlist Manager
Abbott Laboratories Logo
Abbott Laboratories
NYSE:ABT
Watchlist
Price: 117.65 USD -0.8%
Market Cap: 204.7B USD
Have any thoughts about
Abbott Laboratories?
Write Note

Abbott Laboratories
Operating Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Abbott Laboratories
Operating Income Peer Comparison

Comparables:
BDX
BSX
EW
SYK
ISRG

Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors

Company Operating Income CAGR 3Y CAGR 5Y CAGR 10Y
Abbott Laboratories
NYSE:ABT
Operating Income
$6.9B
CAGR 3-Years
-7%
CAGR 5-Years
10%
CAGR 10-Years
11%
Becton Dickinson and Co
NYSE:BDX
Operating Income
$2.9B
CAGR 3-Years
18%
CAGR 5-Years
2%
CAGR 10-Years
9%
Boston Scientific Corp
NYSE:BSX
Operating Income
$2.9B
CAGR 3-Years
20%
CAGR 5-Years
10%
CAGR 10-Years
11%
Edwards Lifesciences Corp
NYSE:EW
Operating Income
$1.6B
CAGR 3-Years
-2%
CAGR 5-Years
6%
CAGR 10-Years
13%
Stryker Corp
NYSE:SYK
Operating Income
$4.8B
CAGR 3-Years
11%
CAGR 5-Years
8%
CAGR 10-Years
8%
Intuitive Surgical Inc
NASDAQ:ISRG
Operating Income
$2.1B
CAGR 3-Years
5%
CAGR 5-Years
10%
CAGR 10-Years
14%

See Also

What is Abbott Laboratories's Operating Income?
Operating Income
6.9B USD

Based on the financial report for Sep 30, 2024, Abbott Laboratories's Operating Income amounts to 6.9B USD.

What is Abbott Laboratories's Operating Income growth rate?
Operating Income CAGR 10Y
11%

Over the last year, the Operating Income growth was 13%. The average annual Operating Income growth rates for Abbott Laboratories have been -7% over the past three years , 10% over the past five years , and 11% over the past ten years .

Back to Top